Explore 3 Stock Ideas & Industry Insights Download Free Report

China Health Industries Holdings Inc

Healthcare US CHHE

0.0001USD
0.00(0%)

Last update at 2026-06-02T20:00:00Z

Day Range

0.200.22
LowHigh

52 Week Range

0.00010.20
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.00655M
  • Volume1009
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.97494M
  • Revenue TTM0.10M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM -0.00512M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -0.40877M -0.35102M 2.02M 5.02M 4.69M
Minority interest - - - - -
Net income -0.40877M -0.35395M 1.29M 3.55M 3.31M
Selling general administrative 1.29M 0.93M 1.17M 1.78M 1.86M
Selling and marketing expenses - - - - -
Gross profit 0.00022M -0.00148M 3.64M 7.27M 7.04M
Reconciled depreciation 0.69M 0.83M 0.88M 0.81M 0.82M
Ebit - -1.64792M 1.86M 4.89M 4.56M
Ebitda - 0.48M 2.90M 5.82M 5.51M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -1.84260M -1.64792M 1.86M 4.89M 4.56M
Other operating expenses - - - - -
Interest expense - 0.00000M 0.00000M 0.00000M 0.00001M
Tax provision 0.00000M 0.00293M 0.73M 1.47M 1.38M
Interest income 0.11M 0.16M 0.14M 0.13M 0.11M
Net interest income 0.11M 0.16M 0.14M 0.12M 0.11M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.00293M 0.73M 1.47M 1.38M
Total revenue 0.11M 0.00027M 6.49M 9.93M 9.28M
Total operating expenses 1.95M 1.65M 4.63M 5.04M 4.71M
Cost of revenue 0.11M 0.00175M 2.85M 2.66M 2.24M
Total other income expense net 1.32M 1.14M 0.02M 0.00005M 0.02M
Discontinued operations - - - - -
Net income from continuing ops -0.40877M -0.35395M 1.29M 3.55M 3.31M
Net income applicable to common shares - -0.35395M 1.29M 3.55M 3.31M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 45.08M 50.75M 53.89M 48.24M 45.75M
Intangible assets 0.96M 1.41M 1.96M 2.25M 2.78M
Earning assets - - - - -
Other current assets - 0.24M 0.24M 0.04M 0.02M
Total liab 5.97M 7.94M 9.11M 8.57M 8.57M
Total stockholder equity 39.11M 42.80M 44.77M 39.67M 37.18M
Deferred long term liab - - - - -
Other current liab - 0.58M 0.26M 0.46M 0.65M
Common stock - 0.00655M 0.00655M 0.00655M 0.00655M
Capital stock 0.00655M 0.00655M 0.00655M 0.00655M 0.00655M
Retained earnings 41.29M 41.74M 42.09M 40.80M 37.25M
Other liab - - - - -
Good will - - - - -
Other assets - - 0.00293M 0.00581M 0.01M
Cash 0.05M 44.79M 44.35M 36.07M 35.51M
Cash and equivalents - - - - -
Total current liabilities 5.97M 7.94M 9.11M 8.57M 8.57M
Current deferred revenue - - - - -
Net debt 5.11M - - - -
Short term debt - - - - 6.96M
Short long term debt 5.15M 6.76M 8.08M 7.26M 6.96M
Short long term debt total - - - - -
Other stockholder equity - 0.54M 2.16M -1.65874M -0.59365M
Property plant equipment - 3.74M 4.19M 4.19M 4.55M
Total current assets 40.97M 45.60M 47.73M 41.79M 38.41M
Long term investments - - - - -
Net tangible assets - 41.39M 42.81M 37.42M 34.40M
Short term investments - - - - -
Net receivables 0.00000M 0.04M 2.38M 4.66M 2.02M
Long term debt - - - - -
Inventory 0.04M 0.52M 0.76M 1.01M 0.86M
Accounts payable 0.29M 0.33M 0.41M 0.41M 0.50M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 7.35M
Deferred long term asset charges - - - - -
Non current assets total 4.11M 5.15M 6.16M 6.44M 7.35M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments 0.00000M 0.00000M -0.01366M -0.15197M -0.12399M
Change to liabilities - -0.05791M -0.03655M -0.07736M 0.11M
Total cashflows from investing activities - - -0.01366M -0.15197M -0.12399M
Net borrowings - - - - -
Total cash from financing activities - 0.00000M 0.00000M 0.00000M 0.00000M
Change to operating activities - -0.74784M 0.89M 1.23M 1.59M
Net income -0.40877M -0.35395M 1.29M 3.55M 3.31M
Change in cash -44.74275M 0.44M 8.27M 0.56M 2.89M
Begin period cash flow 44.79M 44.35M 36.07M 35.51M 32.61M
End period cash flow 0.05M 44.79M 44.35M 36.07M 35.51M
Total cash from operating activities -42.27250M 2.12M 5.56M 2.40M 5.12M
Issuance of capital stock - - - - -
Depreciation 0.69M 0.83M 0.88M 0.81M 0.82M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.46M 0.20M 0.15M -0.18899M -0.16151M
Change to account receivables 0.00281M 2.29M 2.67M -2.71149M -0.60690M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome - -0.00670M -0.01033M -0.00536M -0.13720M
Capital expenditures 0.00000M 0.00000M 0.01M 0.16M 0.15M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -42.55680M 1.65M 3.40M -1.94558M 1.13M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -42.27250M 2.12M 5.54M 2.25M 4.96M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CHHE
China Health Industries Holdings Inc
- -% 0.0001 - - 0.07 0.49 57.60 -25.7767
ZTS
Zoetis Inc
1.20 1.57% 77.59 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
0.64 2.10% 31.05 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
- -% 153.91 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG
-0.79 1.89% 40.92 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

Profile

China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds. It also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand. In addition, the company offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements. Further, it manufactures and sells various types of medical drugs, such as enema glycerini, umguentumacidi borici camphoratum, ge hong beriberi water, pelvic inflammation suppository, injury and paralysis tincture, indometacin and furazolidone suppositories, injury and rheumatism relieving paste, refining goupi cream, muskiness pain relieving paste, muskiness bone strengthener paste, matrine suppositories, ethacriding lactate solution, iodine tincture, mercurochrome solution, hydrogen peroxide solution, halcinonide cream, compound fluocinonide tincture, and policresulen vaginal suppository. The company primarily sells its products through sales personnel and sales agents. China Health Industries Holdings, Inc. was founded in 1996 and is based in Harbin City, the People's Republic of China.

China Health Industries Holdings Inc

3199-1 Longxiang Road, Harbin, China, 150028

Key Executives

Name Title Year Born
Mr. Sun Xin Chairman, CEO, CFO & Treasurer 1966

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions